1 Top Stock to Buy Hand Over Fist Before the Nasdaq Soars Higher in 2026

Arm Holdings reported strong underlying performance with overall revenue up 34% year-over-year and earnings up 30% in Q2 fiscal 2026 (quarter ended Sept. 30, 2025), driven by higher royalties from its AI-focused Armv9 architecture and a doubling of data-center royalty revenue year-over-year. The company grew its cloud share by 11 percentage points to 20% at the end of fiscal 2025, and hyperscaler capex trends support further adoption of custom Arm-based chips; however, the stock has pulled back ~40% from its late‑Oct 2025 52-week high and still trades at a high trailing P/E (138x) but a more reasonable forward P/E (~47x). Consensus from 41 analysts places a $180 median target (≈67% upside), suggesting upside if Arm outpaces expectations, while valuation and near-term execution remain the main risks for investors.

Analysis

Market structure: Arm (ARM) is a leveraged play on hyperscaler AI capex: rising cloud custom SoC adoption and Armv9’s higher royalties shift value from fabs to IP licensors. Expect Arm’s revenue mix to tilt further toward higher-margin data-center royalties (royalty growth can drive EPS >30% YoY if data-center share rises from 20% to 30% in 12–24 months). Downstream winners include cloud providers and EDA/IP firms; legacy x86 CPU suppliers and GPU incumbents face margin pressure on verticalized, Arm-based solutions.

Risk assessment: Key tail risks are regulatory export controls (China) or a sudden hyperscaler pivot to RISC‑V or in-house ISAs—each a 10–15% low-probability, high-impact event that could cut royalty growth by >50% within 12 months. Near-term (days–weeks) price moves will track sentiment and IV; medium-term (3–12 months) depends on quarterly royalty cadence and design-win disclosures; long-term (2+ years) depends on Armv9 adoption and ability to maintain higher royalty rates vs competitive undercutting.

Trade implications: Tactical long with hedges is warranted. Use concentrated equity or bullish call spreads to capture upside to the $180 analyst median while limiting capital at risk; consider pair trades to neutralize sector beta (long ARM, short a high‑beta AI hardware name). Monitor IV and liquidity; if implied vol >60% favor defined‑risk spreads over naked calls.

Contrarian angles: Consensus prizes AI tailwinds but underestimates licensing concentration (top hyperscalers can negotiate lower rates) and RISC‑V momentum. The 47x forward EPS embeds >30%+ EPS acceleration; if royalty growth disappoints by 10–20% next two quarters, multiple compresses materially. Historically, IP winners re-rate only after multi-quarter visible royalty growth—don’t pay up for story without sequential proof.

Key Decisions for Investors

• Establish a 2–3% portfolio long position in ARM (ticker: ARM) using equity today (~$108 implied by article); set a hard stop-loss at 25% below entry and scale to 5% if ARM drops to $85–$95 (accumulate on evidence: two consecutive quarters of >25% YoY royalty growth).
• Buy a 12-month, defined-risk call spread to leverage upside: purchase ARM Jan 2027 110/180 call spread (ratio sized to equal ~1–1.5% notional exposure) to cap max loss while retaining upside to the $180 target; close if ARM trades >$180 or if implied royalty growth <15% YoY in two consecutive quarters.
• Construct a pair: long ARM (2%) / short NVDA (1–1.5%) to reduce beta and isolate licensing upside vs pure-play GPU cyclical risk; rebalance if spread performance diverges >30% intraday or if NVDA reports an upside guide that materially re-rates the AI hardware space.
• Sell a 3-month put spread to opportunistically acquire ARM at a lower cost: sell ARM 3‑month 90/80 put spread sized to add 1–2% if assigned; close if assignment would push total ARM exposure >5% or if ARM’s next-quarter royalty guidance misses consensus by >10 percentage points.
• Triggers to act: trim or exit all ARM exposure if (a) next two quarters show royalty growth <10% YoY, (b) a major hyperscaler publicly shifts primary ISA away from Arm, or (c) new export controls materially restrict China-related royalties (each event to prompt a 50–100% position reduction within 5 trading days).